Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Other Non-Current Liabilities: 2011-2024

Historic Other Non-Current Liabilities for Adma Biologics (ADMA) over the last 11 years, with Dec 2024 value amounting to $360,000.

  • Adma Biologics' Other Non-Current Liabilities fell 76.00% to $90,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $90,000, marking a year-over-year decrease of 76.00%. This contributed to the annual value of $360,000 for FY2024, which is 14.08% down from last year.
  • According to the latest figures from FY2024, Adma Biologics' Other Non-Current Liabilities is $360,000, which was down 14.08% from $419,000 recorded in FY2023.
  • Over the past 5 years, Adma Biologics' Other Non-Current Liabilities peaked at $419,000 during FY2023, and registered a low of $54,886 during FY2020.
  • Over the past 3 years, Adma Biologics' median Other Non-Current Liabilities value was $360,000 (recorded in 2024), while the average stood at $376,333.
  • As far as peak fluctuations go, Adma Biologics' Other Non-Current Liabilities skyrocketed by 623.96% in 2021, and later fell by 14.08% in 2024.
  • Adma Biologics' Other Non-Current Liabilities (Yearly) stood at $54,886 in 2020, then skyrocketed by 623.96% to $397,351 in 2021, then dropped by 11.92% to $350,000 in 2022, then climbed by 19.71% to $419,000 in 2023, then fell by 14.08% to $360,000 in 2024.